Post-approval studies (Phase 4)Ended earlyNCT03296033
What this trial is testing
Residual Anti-Xa Activity After Last Treatment Dose of Enoxaparin
Who this might be right for
Anticoagulants and Bleeding DisordersSurgeryRegional Anesthesia Morbidity
Wake Forest University Health Sciences 122